The CXCL12-CXCR4/CXCR7 signaling axis plays a central role through autocrine/paracrine mechanisms in the progression of various tumors, including leukemia, breast cancer, lung cancer, prostate cancer, and multiple myeloma. Here, CXCR4 is linked to breast carcinoma.